Tarsus Pharmaceuticals (TARS) Research & Development (2020 - 2025)
Historic Research & Development for Tarsus Pharmaceuticals (TARS) over the last 6 years, with Q3 2025 value amounting to $16.3 million.
- Tarsus Pharmaceuticals' Research & Development rose 3426.78% to $16.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $63.2 million, marking a year-over-year increase of 2678.15%. This contributed to the annual value of $53.4 million for FY2024, which is 610.99% up from last year.
- Per Tarsus Pharmaceuticals' latest filing, its Research & Development stood at $16.3 million for Q3 2025, which was up 3426.78% from $15.6 million recorded in Q2 2025.
- Tarsus Pharmaceuticals' 5-year Research & Development high stood at $16.9 million for Q4 2024, and its period low was $7.2 million during Q2 2021.
- Moreover, its 5-year median value for Research & Development was $12.1 million (2024), whereas its average is $12.3 million.
- In the last 5 years, Tarsus Pharmaceuticals' Research & Development skyrocketed by 97546.3% in 2021 and then plummeted by 2570.57% in 2022.
- Tarsus Pharmaceuticals' Research & Development (Quarter) stood at $8.0 million in 2021, then grew by 24.76% to $10.0 million in 2022, then surged by 32.68% to $13.3 million in 2023, then rose by 26.82% to $16.9 million in 2024, then decreased by 3.49% to $16.3 million in 2025.
- Its Research & Development stands at $16.3 million for Q3 2025, versus $15.6 million for Q2 2025 and $14.4 million for Q1 2025.